The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is a general consensus that the acute phase protein, C-reactive protein (CRP), is a sensitive biomarker for cigarette smoke-induced inflammation10–12”
From The effect of smoking on chronic inflammation, immune function and blood cell composition (2020) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
The pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394
Multiple Imputation by Chained Equations (MICE): Implementation in Stata
Royston, P., & White, I. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i04 · Cited by 1,248
Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2167 · Cited by 539
Inoue-Choi, M., Liao, L. M., Reyes-Guzman, C., Hartge, P., Caporaso, N., & Freedman, N. D. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.7511 · Cited by 212
The role of interleukin-18 in the metabolic syndrome
Trøseid, M., Seljeflot, I., & Arnesen, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-11 · Cited by 155
Research works printed but not linked: 39
- 2014, The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, Atlanta GA
- 2016, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1659, 10.1016/S0140-6736(16)31679-8 · DOI · Paper page
- GN Connolly, 2008, Trends in the use of cigarettes and other tobacco products, 2000–2007, JAMA, 299, 2629, 10.1001/jama.299.22.2629 · DOI
- BG Southwell, 2012, The marketing of dissolvable tobacco: social science and public policy research needs, Am J Health Promot, 26, 331, 10.4278/ajhp.111004-CIT-357 · DOI
- 2012, Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General, Atlanta GA
- JW McEvoy, 2015, Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis, Arterioscler Thromb Vasc Biol, 35, 1002, 10.1161/ATVBAHA.114.304960 · DOI
- JW McEvoy, 2015, Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis, Arterioscler Thromb Vasc Biol, 35, 700, 10.1161/ATVBAHA.114.304562 · DOI
- YS Levitzky, 2008, Relation of smoking status to a panel of inflammatory markers: the framingham offspring, Atherosclerosis, 201, 217, 10.1016/j.atherosclerosis.2007.12.058 · DOI
- M Al Rifai, The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA), Atherosclerosis
- J Liu, 2011, Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers, Cancer Epidemiol Biomarkers Prev, 20, 1760, 10.1158/1055-9965.EPI-10-0987 · DOI
- W Koenig, 1999, C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992, Circulation, 99, 237, 10.1161/01.CIR.99.2.237 · DOI
- J Helmersson, 2005, Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men, Atherosclerosis, 181, 201, 10.1016/j.atherosclerosis.2004.11.026 · DOI
- CX Kim, 2010, Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study, PLoS One, 5, e9065, 10.1371/journal.pone.0009065 · DOI
- PM Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202 · DOI · Paper page
- AD Blann, 2003, The adhesion molecule P-selectin and cardiovascular disease, Eur Heart J, 24, 2166, 10.1016/j.ehj.2003.08.021 · DOI
- SJ Hwang, 1997, Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study, Circulation, 96, 4219, 10.1161/01.CIR.96.12.4219 · DOI
- R Schulz, 2009, Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?, Circulation, 119, 1355, 10.1161/CIRCULATIONAHA.108.846105 · DOI
- PM Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767 · DOI · Paper page
- DH McDermott, 2005, CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study, Circulation, 112, 1113, 10.1161/CIRCULATIONAHA.105.543579 · DOI
- M Karakas, 2012, Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study, J Intern Med, 271, 43, 10.1111/j.1365-2796.2011.02397.x · DOI
- JB Lindsey, 2009, Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications, Diab Vasc Dis Res, 6, 7, 10.3132/dvdr.2009.002 · DOI
- CM Dollery, 2006, Atherosclerosis and proteinase activation, Cardiovasc Res, 69, 625, 10.1016/j.cardiores.2005.11.003 · DOI
- ZS Galis, 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly, Circ Res, 90, 251, 10.1161/res.90.3.251 · DOI
- H Kai, 1998, Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes, J Am Coll Cardiol, 32, 368, 10.1016/S0735-1097(98)00250-2 · DOI
- CB Granger, 2004, National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report, Circulation, 109, 1697, 10.1161/01.CIR.0000121563.47232.2A · DOI
- 2002, Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP), Hypertension, 39, 3, 10.1161/hy1201.100415 · DOI
- AA Ellington, 2009, Measurement and quality control issues in multiplex protein assays: a case study, Clin Chem, 55, 1092, 10.1373/clinchem.2008.120717 · DOI
- JO Westgard, 1981, A multi-rule Shewhart chart for quality control in clinical chemistry, Clin Chem, 27, 493, 10.1093/clinchem/27.3.493 · DOI
- AD Rule, 2004, Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease, Ann Intern Med, 141, 929, 10.7326/0003-4819-141-12-200412210-00009 · DOI
- SL Zeger, 1986, Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121, 10.2307/2531248 · DOI
- R Newson, 2003, Stata tip 1: The eform() option of regress, The Stata Journal, 3, 445, 10.1177/1536867X0400300412 · DOI
- R Ross, 1999, Atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 · DOI · Paper page
- MS Shiels, 2014, Cigarette smoking and variations in systemic immune and inflammation markers, J Natl Cancer Inst, 106, 10.1093/jnci/dju294 · DOI
- CC King, 2017, Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk, Arterioscler Thromb Vasc Biol, 37, 374, 10.1161/ATVBAHA.116.308728 · DOI
- RB Goncalves, 2011, Impact of smoking on inflammation: overview of molecular mechanisms, Inflamm Res, 60, 409, 10.1007/s00011-011-0308-7 · DOI
- O Rom, 2013, Cigarette smoking and inflammation revisited, Respir Physiol Neurobiol, 187, 5, 10.1016/j.resp.2013.01.013 · DOI
- PM Ridker, 2001, Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, JAMA, 285, 2481, 10.1001/jama.285.19.2481 · DOI
- M Ohsawa, 2005, CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers, Prev Med, 41, 651, 10.1016/j.ypmed.2005.02.002 · DOI
- Y Zhang, 2016, Self-reported smoking, serum cotinine, and blood DNA methylation, Environ Res, 146, 395, 10.1016/j.envres.2016.01.026 · DOI
Cited by
The effect of smoking on chronic inflammation, immune function and blood cell composition
Elisia, I., Lam, V., Cho, B., Hay, M., Li, M. Y., Yeung, M., Bu, L., Jia, W., Norton, N., Lam, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76556-7 · Cited by 263
Metadata
- Authors
- Tibuakuu, M., Kamimura, D., Kianoush, S., DeFilippis, A. P., Al Rifai, M., Reynolds, L. M., White, W. B., Butler, K. R., Mosley, T. H., Turner, S. T., Kullo, I. J., Hall, M. E., & Blaha, M. J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-09-18
- Volume
- 12
- Issue
- 9
- Pages
- e0184914
- ISSN
- 1932-6203
- Cited by
- 77
- References
- 6
- Language
- en
- Funders
- U.S. Food and Drug Administration (P50 HL120163-01)
- National Institutes of Health (U01-HL054463, U01-HL054464, U01-HL081331)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.